{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:54:18Z","timestamp":1787799258527,"version":"build-2784847793"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1007\/bf03165085","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T07:15:00Z","timestamp":1254294900000},"page":"44-46","source":"Crossref","is-referenced-by-count":15,"title":["Effects of hormone replacement therapy on coagulation and fibrinolysis in postmenopausal women"],"prefix":"10.1007","volume":"76","author":[{"given":"Kwang Kon","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03165085_CR1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1055\/s-0037-1615889","volume":"82","author":"KK Koh","year":"1999","unstructured":"Koh KK, Horne MK III, Cannon RO III. Effects of hormone replacement therapy on coagulation and fibrinolysis in postmenopausal women [Review].Thromb Haemost. 1999;82:626\u2013633.","journal-title":"Thromb Haemost"},{"key":"BF03165085_CR2","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(80)91550-0","volume":"1","author":"LE Bottiger","year":"1980","unstructured":"Bottiger LE, Boman G, Eklund G, Westerholm B. Oral contraceptives and thromboembolic disease; effects of lowering oestrogen content.Lancet. 1980;1:1097\u20131101.","journal-title":"Lancet"},{"key":"BF03165085_CR3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-0038-1646283","volume":"68","author":"YG Caine","year":"1992","unstructured":"Caine YG, Bauer KA, Barzegar S, et al. Coagulation activation following estrogen administration to postmenopausal women.Thromb Haemost. 1992;68:392\u2013395.","journal-title":"Thromb Haemost"},{"key":"BF03165085_CR4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(96)07113-9","volume":"348","author":"E Daly","year":"1996","unstructured":"Daly E, Vessey MP, Hawkins MM, et al. Risk of venous thromboembolism in users of hormone replacement therapy.Lancet. 1996;348:977\u2013980.","journal-title":"Lancet"},{"key":"BF03165085_CR5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(96)07114-0","volume":"348","author":"H Jick","year":"1996","unstructured":"Jick H, Derby LE, Myers MW, Vasilakis C, Newton KM. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens.Lancet. 1996;348:981\u2013983.","journal-title":"Lancet"},{"key":"BF03165085_CR6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/bmj.312.7029.473","volume":"312","author":"Medical Research Council\u2019s General Practice Research Framework","year":"1996","unstructured":"Medical Research Council\u2019s General Practice Research Framework. Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy.BMJ. 1996;312:473\u2013478.","journal-title":"BMJ"},{"key":"BF03165085_CR7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(96)07308-4","volume":"348","author":"F Grodstein","year":"1996","unstructured":"Grodstein F, Stampfer MJ, Goldhaber SZ, et al. Prospective study of exogenous hormones and risk of pulmonary embolism in women.Lancet. 1996;348:983\u2013987.","journal-title":"Lancet"},{"key":"BF03165085_CR8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","volume":"280","author":"S Hulley","year":"1998","unstructured":"Hulley S, Grady D, Bush T, et al. The Heart and Estrogen\/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women.JAMA. 1998;280:605\u2013613.","journal-title":"JAMA"},{"key":"BF03165085_CR9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199608153350701","volume":"335","author":"F Grodstein","year":"1996","unstructured":"Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.N Engl J Med. 1996;335:453\u2013461.","journal-title":"N Engl J Med"},{"key":"BF03165085_CR10","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1161\/01.ATV.17.11.3071","volume":"17","author":"P-Y Scarabin","year":"1997","unstructured":"Scarabin P-Y, Alhenc-Gelas M, Plu-Bureau G, Taisne P, Agher R, Aiach M. Effects of oral and transdermal estrogen\/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.Arterioscler Thromb Vasc Biol. 1997;17:3071\u20133078.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BF03165085_CR11","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0002-8703(97)70062-0","volume":"134","author":"GYH Lip","year":"1997","unstructured":"Lip GYH, Blann AD, Jones AF, Beevers DG. Effects of hormone-replacement therapy on hemostatic factors, lipid factors, and endothelial function in women undergoing surgical menopause: implications for prevention of atherosclerosis.Am Heart J. 1997;134:764\u2013771.","journal-title":"Am Heart J"},{"key":"BF03165085_CR12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/bmj.312.7029.473","volume":"312","author":"Medical Research Council\u2019s General Practice Research Framework","year":"1996","unstructured":"Medical Research Council\u2019s General Practice Research Framework. Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy.BMJ. 1996;312:473\u2013478.","journal-title":"BMJ"},{"key":"BF03165085_CR13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/01.ATV.18.1.92","volume":"18","author":"DA Bellinger","year":"1998","unstructured":"Bellinger DA, Williams JK, Adams MR, Honore EK, Bender DE. Oral contraceptives and hormone replacement therapy do not increase the incidence of arterial thrombosis in a nonhuman primate model.Arterioscler Thromb Vasc Biol. 1998;18:92\u201399.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BF03165085_CR14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJM199703063361002","volume":"336","author":"KK Koh","year":"1997","unstructured":"Koh KK, Mincemoyer R, Bui MN, et al. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women.N Engl J Med. 1997;336:683\u2013690.","journal-title":"N Engl J Med"},{"key":"BF03165085_CR15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0010-7824(95)00271-5","volume":"53","author":"UH Winkler","year":"1996","unstructured":"Winkler UH, Schindler AE, Endrikat J, et al. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20\u03bcg and 30 g ethinylestradiol.Contraception. 1996;53:75\u201384.","journal-title":"Contraception"},{"key":"BF03165085_CR16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0002-9149(98)00891-1","volume":"83","author":"KK Koh","year":"1999","unstructured":"Koh KK, Horne MK III, Csako G, et al. Relation of fibrinolytic potentiation by estrogen to coagulation pathway activation in postmenopausal women.Am J Cardiol. 1999;83:466\u2013469.","journal-title":"Am J Cardiol"},{"key":"BF03165085_CR17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.ATV.19.4.893","volume":"19","author":"M Cushman","year":"1999","unstructured":"Cushman M, Meilahn EN, Psaty BM, et al. Hormone replacement therapy, inflammation, and hemostasis in elderly women.Arterioscler Thromb Vasc Biol. 1999;19:893\u2013899.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BF03165085_CR18","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0002-9149(01)02126-9","volume":"88","author":"KK Koh","year":"2001","unstructured":"Koh KK, Ahn JY, Kang MH, et al. Effects of hormone replacement therapy on plaque stability, inflammation, and fibrinolysis in hypertensive or overweight postmenopausal women.Am J Cardiol. 2001;88:1423\u20131426.","journal-title":"Am J Cardiol"},{"key":"BF03165085_CR19","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJM199604253341703","volume":"334","author":"EJ Weiss","year":"1996","unstructured":"Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.N Engl J Med. 1996;334:1090\u20131094.","journal-title":"N Engl J Med"},{"key":"BF03165085_CR20","doi-asserted-by":"crossref","first-page":"895","DOI":"10.7326\/0003-4819-127-10-199711150-00007","volume":"127","author":"DT Price","year":"1997","unstructured":"Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.Ann Intern Med. 1997;127:895\u2013903.","journal-title":"Ann Intern Med"},{"key":"BF03165085_CR21","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1182\/blood.V89.8.2817","volume":"89","author":"FR Rosendaal","year":"1997","unstructured":"Rosendaal FR, Siscovick DS, Schwartz SM, et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women.Blood. 1997;89:2817\u20132821.","journal-title":"Blood"},{"key":"BF03165085_CR22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0002-9149(99)00375-6","volume":"84","author":"CJ Glueck","year":"1999","unstructured":"Glueck CJ, Wang P, Fontaine RN, et al. Effect of exogenous estrogen on atherothrombotic vascular disease risk related to the presence or absence of the Factor V Leiden mutation (resistance to activated protein C).Am J Cardiol. 1999;84:549\u2013554.","journal-title":"Am J Cardiol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03165085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03165085\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03165085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T16:25:21Z","timestamp":1590164721000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03165085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":22,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["BF03165085"],"URL":"https:\/\/doi.org\/10.1007\/bf03165085","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}